Moderna has said it is filing for regulatory approval in the US, and that its vaccine trials have shown no serious safety concerns.

The US-based company has also said its vaccine was 94.1% effective, with 100% efficacy against severe COVID-19 in its phase three trial.

Efficacy was consistent across age, race and ethnicity, as well as gender, the company has said.

Speaking to Reuters news agency, chief medical officer Dr Tal Zaks said: “We believe that we have a vaccine that is very highly efficacious. We now have the data to prove it.”

You May Also Like

Former officer avoids jail after locking suspect in car that was hit by a train

A former Colorado officer who put a handcuffed woman in a parked…

‘Bankrupt of decency’ – Meghan’s former Suits co-star hits out at Royal Family

The Royal Family’s handling of bullying claims against the Duchess of Sussex…

Liberal against conservative, American against American – the Rittenhouse trial is a troubling snapshot of a divided US

For the past two weeks the steps in front of the grand…

Ghislaine Maxwell and Epstein seen at the Queen’s log cabin in new photos shown to court

Newly released pictures chart Ghislaine Maxwell’s relationship with disgraced billionaire Jeffrey Epstein,…